There are thousands of hereditary diseases that can be detected using current preimplantation genetic diagnosis technology. Chromosomal abnormalities account for 90 percent of pregnancy losses.
Chicago, IL (PRWEB) March 29, 2012
Fertility Centers of Illinois provides advanced fertility techniques to screen for genetic abnormalities. When trying to conceive, it is every couple’s dream to have a healthy, happy baby. For couples predisposed to genetic disease or other risk factors, there may be a possibility of having a baby born with a genetic abnormality.
Some couples may learn that a specific genetic disease is in their family bloodline, which may be passed on. Other couples may be at a higher risk of genetic abnormality due to advanced maternal age. If couples experience recurrent miscarriage or difficulty in carrying a baby to full term, genetic abnormalities may also be a factor. If gone undetected, a genetic abnormality can result in the birth of a child with physical problems, developmental delay or mental retardation. According to the March of Dimes, there are 120,000 babies born per year with a birth defect, largely due to a genetic abnormality.
Advancements in scientific capabilities are now available to help couples grow a healthy family successfully. New technology at Fertility Centers of Illinois called Preimplantation Genetic Screening (PGS) and Preimplantation Genetic Diagnosis (PGD) allow couples to screen embryos for chromosomal abnormalities or detect embryos affected by potentially fatal conditions before In Vitro Fertilization (IVF). PGS screens for chromosomal abnormalities while PGD can detect a disease if the related single genes are known to be present in the couple. When screening for chromosomal abnormalities, like Down Syndrome, the 23 pairs of chromosomes are analyzed, looking for extra copies or missing copies of individual chromosomes. If a specific disease linked to a single gene is present in the family, or the couple each carry a recessive gene for a disease, like cystic fibrosis, affected embryos can be distinguished from the others and only the normal or carrier embryos transferred. There are thousands of hereditary diseases that can be detected using current PGD technology. Combining PGS and PGD is also possible. Once embryos have been screened, doctors select the best quality embryo or embryos to use during IVF, optimizing a couple’s success.
PGS is a procedure that has grown in leaps and bounds in recent years. Cutting-edge scientific capabilities now allow for the screening of all chromosomal pairs, unlike previous screening methods. Chromosomal abnormalities account for 90 percent of pregnancy losses. Fertility treatment methods like PGS can prevent the trauma of losing a pregnancy while providing couples with the most advanced treatment methods available. Many of my patients have successfully used PGS during their family planning in order to increase the chance of a normal baby and to avoid genetic disease.
"As couples plan for their future families, it is important to take all options into consideration. It is my goal to empower couples with the knowledge to make an informed decision with which they are comfortable. Above all, at Fertility Centers of Illinois we are dedicated to helping our patients successfully become parents."
-Edward L. Marut, MD
Reproductive Endocrinologist and Medical Director, Fertility Centers of Illinois
Fertility Centers of Illinois, S.C., is one of the nation's leading fertility treatment practices, providing advanced reproductive endocrinology services in the Chicago area for more than 30 years. FCI physicians, embryologists and support staff are stringently chosen based on educational background, medical skills and their ability to collaborate. With a team of 11 nationally and internationally recognized reproductive physicians who treat thousands of patients each year, the practice has earned a reputation for overcoming hard-to-solve fertility issues. FCI is dedicated to medical and clinical excellence and continues to invest in the latest technologies and research. FCI offers a comprehensive range of fertility treatment options including intrauterine insemination, in vitro fertilization, donor egg, gestational carrier, and preimplantation genetic diagnosis, as well as extensive resources to address financial and emotional needs. Fostering a culture for continuous innovation has made FCI home to the annual Midwest Reproductive Symposium which attracts experts in the field of reproductive endocrinology from around the world. FCI has 10 offices conveniently located throughout the Chicagoland area (Buffalo Grove, Chicago/River North, Crystal Lake, Glenview, Highland Park, Hoffman Estates, Lindenhurst, Naperville, Oakbrook Terrace, and Orland Park). FCI is a member of the Attain Fertility Network which provides discounted fertility treatment programs. For more information visit http://www.fcionline.com